Edwards Lifesciences
1,180 hedge funds and large institutions have $52.9B invested in Edwards Lifesciences in 2021 Q2 according to their latest regulatory filings, with 135 funds opening new positions, 425 increasing their positions, 389 reducing their positions, and 84 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 1,139 → 1,180 (+41)
9% more repeat investments, than reductions
Existing positions increased: 425 | Existing positions reduced: 389
0.55% more ownership
Funds ownership: 81.91% → 82.46% (+0.55%)
Holders
1,180
Holding in Top 10
17
Calls
$289M
Puts
$169M
Top Buyers
| 1 | +$244M | |
| 2 | +$175M | |
| 3 | +$116M | |
| 4 |
1832 Asset Management
Toronto,
Ontario, Canada
|
+$99M |
| 5 |
Man Group
London,
United Kingdom
|
+$85.9M |
Top Sellers
| 1 | -$443M | |
| 2 | -$263M | |
| 3 | -$211M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$93.5M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$69.5M |